Evidence-based analysis: Postoperative gastric bleeding: Etiology and prevention

Surgical Oncology

Volumn 12, Issue 1, 2003, Pages 9-19

  Hiramoto, Jade S ^a   Terdiman, Jonathan P ^b   Norton, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer surgery; Coagulopathy; Gastric bleeding; Liver failure; Prophylaxis; Proton pump inhibitor; Ventilation

Indexed keywords

ANTACID AGENT; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

ALKALOSIS; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONFUSION; CORONARY ARTERY CONSTRICTION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG ACTIVITY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HALLUCINATION; HIGH RISK PATIENT; HUMAN; HYPERMAGNESEMIA; HYPOPHOSPHATEMIA; INCIDENCE; LIVER DYSFUNCTION; LUNG ASPIRATION; PATHOPHYSIOLOGY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SIDE EFFECT; SOMNOLENCE; STOMACH HEMORRHAGE; STOMACH PH; STRESS ULCER; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0345055710     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(02)00073-7     Document Type: Review

References (73)

1. Lucas C.E., Sugawa C., Riddle J., Rector F., Rosenberg B., Walt A.J. Natural history and surgical dilemma of "stress" gastric bleeding. Arch Surg. 102(4):1971;266-273.
2. Ben-Menachem T., McCarthy B.D., Fogel R.et al. Prophylaxis for stress-related gastrointestinal hemorrhage. a cost effectiveness analysis Crit Care Med. 24:1996;338-345.
3. Tryba M., Cook D. Current guidelines on stress ulcer prophylaxis. Drugs. 54(4):1997;581-596.
4. Navab, F, Steingrub J. Stress ulcer. is routine prophylaxis necessary Am J Gastroenterol. 90(5):1995;708-712.
5. Lebovics E., Lee S.S., Dworkin B.M.et al. Upper gastrointestinal bleeding following open heart surgery. Predominant finding of aggressive duodenal ulcer disease. Dig Dis Sci. 36:1991;757-760.
6. Rosen H.R., Vlahakes G.J., Rattner D.W. Fulminant peptic ulcer disease in cardiac surgical patients. pathogenesis, prevention, and management Crit Care Med. 20(3):1992;354-359.
7. Egleston C.V., Wood A.E., Gorey T.F., McGovern E.M. Gastrointestinal complications after cardiac surgery. Ann R Coll Surg Engl. 75:1993;52-56.
8. Bove P.G., Robbing J., Villalba M.R., Glover J.L., Bendick P.J. Incidence and management of gastrointestinal hemorrhage after cardiac surgery. Gastrointest Endosc. 40:1994;P82. (A269).
9. Wijdicks E.F., Fulgham J.R., Batts K.P. Gastrointestinal bleeding in stroke. Stroke. 25:1994;2146-2148.
10. Pimental M., Roberts D.E., Bernstein C.N., Hoppensack M., Duerksen D.R. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 95:2000;2801-2806.
11. Cook D.J., Fuller H.D., Guyatt G.H.et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 330(6):1994;377-381.
12. Skillman J.J., Bushnell L.S., Goldman H., Silen W. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from cute stress ulceration of the stomach. Am J Surg. 117:1969;523-530.
13. Pruitt B.A., Foley F.D., Moncrief J.A. Curling's ulcer. a clinical-pathologic study of 323 cases Ann Surg. 172:1970;523-539.
14. Czaja A.J., McAlhany J.C., Pruitt B.A. Acute gastroduodenal diseae after thermal injury. An endoscopic evaluation of incidence and natural history. N Engl J Med. 291:1974;925-929.
15. Schuster D.P., Rowley H., Feinstein S., McGue M.K., Zuckerman G.R. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med. 76:1984;623-630.
16. Harris S.K., Bone R.C., Ruth W.E. Gastrointestinal hemorrhage in patients in a respiratory intensive care unit. Chest. 72(3):1977;301-304.
17. Terdiman J.P., Ostroff J.W. Gastrointestinal bleeding in the hospitalized patient. a case-control study to assess risk factors, causes, and outcome Am J Med. 104:1998;349-354.
18. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health-Syst Pharm 1999;56:347-79.
19. Martin L.F. Gastrointestinal bleeding in critically ill patients. N Engl J Med. 331(1):1994;51.
20. Cook D., Heyland D., Griffith L.et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med. 12:1999;2812-2817.
21. Terdiman J.P., Ostroff J.W. Risk factors and sources of gastrointestinal bleeding in hospitalized patients. a case control study Gastrointest Endosc. 41(A307):1995;372.
22. Hastings P.R., Skillman J.J., Bushnell L.S., Silen W. Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med. 298(19):1978;1041-1045.
23. Estruch R., Pedrol E., Castells A., Masanes F., Marrades R.M., Urbano-Marquez A. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol. 26:1991;819-826.
24. Metz C.A., Livingston D.H., Smith J.S., Larson G.M., Wilson T.H. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding. a prospective, multicenter, double-blind, randomized trial Crit Care Med. 21(12):1993;1844-1849.
25. Ben-Menachem T., Fogel R., Patel R.V.et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. a randomized, controlled, single-blind study Ann Intern Med. 121(8):1994;568-575.
26. Shuman R.B., Schuster D.P., Zuckerman G.R. Prophylactic therapy for stress ulcer bleeding. a reappraisal Ann Intern Med. 106:1987;562-567.
27. Peura D.A., Johnson L.F. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med. 103(2):1985;173-177.
28. Gottlieb J., Menashe P.I., Cruz E. Gastrointestinal complications in critically ill patients. the intensivists' overview Am J Gastroenterol. 81(4):1986;227-238.
29. Gonzalez E.R. Pathophysiologic changes in the critically ill patient. risk factors for ulceration and altered drug metabolism DICP Ann Pharmacother. 24(suppl):1990;55-57.
30. Moody F.G., Cheung L.Y. Stress ulcers. their pathogenesis, diagnosis, and treatment Surg Clin North Am. 56(6):1976;1469-1478.
31. Ritchie W.P. Role of bile acid reflux in acute hemorrhagic gastritis. World J Surg. 5:1981;189-198.
32. Peura D.A. Stress-related mucosal damage. Clin Ther. 8(supplA):1986;14-23.
33. Zinner M., Zuidema G.D., Smith P.A., Mignosa M. The prevention of upper gastointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet. 153:1981;214-220.
34. Thompson J.C., Walker J.P. Indications for the use of parenteral H2-receptor antagonists. Am J Med. 77(Suppl 5B):1984;111-115.
35. Kauffman G.L. Mucosal damage to the stomach. how, when and why? Scand J Gastroenterol. 19(Suppl 105):1984;19-26.
36. Schiessel R., Feil W., Wenzl E. Mechanisms of stress ulceration and implications for treatment. Gastroenterol Clin North Am. 19:1990;101-120.
37. Fogelman M.J., Garvey J.M. Acute gastroduodenal ulceration incident to surgery and disease. Analysis of eighty-eight cases. Am J Surg. 112:1966;651-655.
38. Zimmerman J., Meroz Y., Arnon R., Tsvang E., Siguencia J. Predictors of mortality in hospitalized patients with secondary upper gastrointestinal haemorrhage. J Int Med. 237:1995;331-337.
39. Terdiman Jp, Ostroff J.W. Bleeding ulcer disease occurring in hospitalized patients is distinct in etiology and outcome from that which occurs in outpatients. Gastrointest Endosc. 41:1995;372. (A306).
40. Cook D.J., Witt L.G., Cook R.J., Guyatt G.H. Stress ulcer prophylaxis in the critically ill. a meta-analysis Am J Med. 91:1991;519-527.
41. Tryba M. Prophylaxis of stress ulcer bleeding - a meta-analysis. J Clin Gastroenterol. 13(suppl2):1991;S44-S55.
42. Cook D.J., Reeve B.K., Guyatt G.et al. Stress ulcer prophylaxis in critically ill patients - resolving discordant meta-analyses. J Am Med Assoc. 275:1996;308-314.
43. Cook D., Guyatt G., Marshall J.et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 338(12):1998;791-797.
44. Winterbauer R.H., Durning R.B., Barron E., McFadden M.C. Aspirated nasogastric feeding solution detected by glucose strips. Ann Intern Med. 95:1981;67-68.
45. Kingston G.W., Phang P.T., Leathley M.J. Increased incidence of nosocomial pneumonia in mechanically ventilated patients with subclinical aspiration. Am J Surg. 161:1991;589-592.
46. Bonten M.J.M., Gaillard C.A., de Leeuw P.W., Stobberingh E.E. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis. 24:1997;309-319.
47. Tryba M., Cook D.J. Gastric alkalinization, pneumonia, and systemic infections. the controversy Scand J Gastroenterol. 30(Suppl 210):1995;53-59.
48. Morris D.L., Youngs D., Burdon D.W., Keighley M.R.B. The influence of sucralfate or cimetidine on gastric juice pH, bacterial flora and mutagenicity. Dig Surg. 1:1984;6-9.
49. Laws H.L., Palmer M.D., Donald J.M., Bryant J.W., Boudreaux A.M., Wheeler A.S. Effects of preoperative medications on gastric pH, volume, and flora. Ann Surg. 203(6):1986;614-619.
50. Ruddell W.S.J., Axon A.T.R., Findlay J.M., Bartholomew B.A., Hill M.J. Effect of cimetidine on the gastric bacterial flora. Lancet. I:1980;672-674.
51. Bresalier R.S., Grendell J.H., Cello J.P., Meyer A.A. Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med. 83(Suppl 3b):1987;110-116.
52. Szabo S., Hollander D. Pathways of gastrointestinal protection and repair. mechanisms of action of sucralfate Am J Med. 86(Suppl 6A):1989;23-31.
53. Bragman S.G.L., Pankhurst C.L., Casewell M.W. Activity of sucralfate (sucrose octa-sulphate), an anti-ulcer agent, against opportunistic gram-negative bacilli. J Antimicrob Chemother. 36:1995;703-706.
54. Tryba M., Mantey-Stiers F. Antibacterial activity of sucralfate in human gastric juice. Am J Med. 83(Suppl 3B):1987;125-127.
55. Thomason M.H., Payseur E.S., Hakenwerth A.M.et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. J Trauma Inj Infect Crit Care. 41(3):1996;503-508.
56. Ephgrave K.S., Kleiman-Wexler R., Pfaller M.et al. Effects of sucralfate vs antacids on gastric pathogens. Arch Surg. 133:1998;251-257.
57. Ortiz J.E., Sottile F.D., Sigel P., Nasraway S.A. Gastric colonization as a consequence of stress ulcer prophylaxis. a prospective, randomized trial Pharmacotherapy. 18(3):1998;486-491.
58. Prod'Hom G., Leuenberger P., Koerfer J.et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomied controlled trial. Ann Int Med. 120:1994;653-662.
59. Tryba M. Side effects of stress bleeding prophylaxis. Am J Med. 86(Suppl 6A):1989;85-93.
60. Gonzalez E.R., Morkunas A.R. Prophylaxis of stress ulcers. antacid titration vs. histamine 2-receptor blockade Drug Intell Clin Pharm. 19:1985;807-811.
61. Tryba M., Kurz-Muller K., Donner B. Plasma aluminum concentrations in long-term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate. Crit Care Med. 22(11):1994;1769-1773.
62. Burgess E., Muruve D., Audette R. Aluminum absorption and excretion folowing sucralfate therapy in chronic renal insufficieny. Am J Med. 92:1992;471-475.
63. Moore J.G., Coburn J.W., Sanders M.C., McSorley D.J., Sirgo M.A. Effects of sucralfate and ranitidine on aluminum concentrations in elderly volunteers. Pharmacotherapy. 15(6):1995;742-746.
64. Pitimana-aree S., Forrest D., Brown G.et al. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med. 24:1998;217-223.
65. Schumock G.T., Lam N.P., Winkler S.R.et al. Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients. Pharmacoeconomics. 9:1996;455-466.
66. Devlin J.W., Claire K.S., Dulchavsky S.A., Tyburski J.G. Impact of trauma stress ulcer prophylaxis guidelines on drug cost and frequency of major gastrointestinal bleeding. Pharmacotherapy. 19(4):1999;452-460.
67. Levy M.J., Seelig C.B., Robinson N.J., Ranney J.E. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 42(6):1997;1255-1259.
68. Balaban D.H., Duckworth C.W., Peura D.A. Nasogastric omeprazole. effects on gastric pH in critically ill patients Am J Gastroenterol. 92(1):1997;79-83.
69. Phillips J.O., Metzler M.H., Palmieri T.L., Huckfeldt R.E., Dahl N.G. A prospective study of dimplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med. 24(11):1996;1793-1800.
70. Lasky M.R., Metzler M.H., Phillips J.O. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma Inj Infect Crit Care. 44(3):1998;527-533.
71. Hartmann M., Ehrlich A., Fuder H.et al. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole. Aliment Pharmacol Ther. 12:1998;1027-1032.
72. Schepp W. Proton pump inhibitory therapy. then and now Yale J Biol Med. 69:1996;175-186.
73. Lam N.P., Le P.T., Crawford S.Y., Patel S. National survey of stress ulcer prophylaxis. Crit Care Med. 27(1):1999;98-103.